Global Portfolio Associate Director

The position

As an Associate Director, New Product Planning Diabetes you will be commercially responsible for early pipeline projects within the Diabetes area. You will work with the new product planning team to develop and deliver (amongst other things): Target product profiles (TPP) Early positioning Estimation of sales and patient potential Full project valuations (NPV and eNPV) for mature projects The above will be based on collecting and conducting primary and secondary market research on market preferences and shaping these insights into actionable commercial recommendations. This position is a great opportunity to make your impact on a truly global scale by: Conducting commercial assessments to enable key project decisions and aligning these through the Early Commercial Team Driving commercial input for the Product Development Plan and creating financial valuations of assets as they prepare to enter Phase 2 clinical development Participating in portfolio assessments and development of commercial guidance to research, as well as contributing to the annual value assessment of the late-stage development portfolio. Qualifications A Master’s degree in business or economics combined with extensive skills in natural science, or a scientific Master’s degree combined with strong commercial experience. Minimum 5 years of experience working in a pharmaceutical company is required. Experience working in a New Product Planning team or similar functions such as early portfolio or commercial analytics is preferred. Strong financial and analytical skills with a proven ability to translate analysis into insights and recommendations. Previous experience from working with/within: Diabetes or related therapy areas, analytical function in a Commercial team, or other key functions in the drug development value chain (e.g., R&D, Medical Affairs, Regulatory Affairs) would be advantageous. Excellent interpersonal skills are expected for this position, as it requires working with multiple stakeholders in the company. A track record of delivering high quality and finding new ways to achieve goals is also necessary. Being proactive and inspired by ways of working smarter is important. Additionally, you have demonstrated the ability to work individually as well as part of a team on multiple projects in parallel. Excellent written and spoken English with strong communication skills will be required. About the department The Diabetes Early Portfolio & Insights (EP&I) functional area sets the commercial direction for Novo Nordisk’s future drug portfolio within Diabetes. The EP&I area consists of departments covering New Product Planning, Competitive Intelligence, Therapy Area Strategy, Customer Insights, and Forecasting. Within the EP&I functional area, the NPP department holds the commercial responsibility for the early portfolio of projects across the therapeutic area. In the NPP department, you will join a team of 8, all with varying backgrounds across commercial, finance, science, and medical, and you will work in collaboration with the broader NPP team across all of Novo Nordisk’s therapy areas. Together with our good colleagues across Novo Nordisk, we are proud to be driving the long-term commercial success of Novo Nordisk. In the New Product Planning department, we are dedicated to delivering top-quality quantitative and qualitative commercial assessments to enable critical project and portfolio decisions. While sharing a pursuit of ambitious goals we’re focused on maintaining a healthy and creative work culture and work-life balance. On a daily basis, you will work in a global context but interact primarily with headquarters functions across a diverse network of internal colleagues from Research & Development, Commercial, Market Access & Pricing, Strategic Finance, Regulatory, Medical, and Product Supply. You will report to the Director and Head of Diabetes NPP. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.